Maarten Ijzerman

Evaluating the resource implications of different service delivery models for offering additional genomic findings.

Martin Vu, Koen Degeling, Melissa Martyn, Elly Lynch, Belinda Chong, Clara Gaff, Maarten J IJzerman

Journal article  |  2020  |  Genetics in Medicine

PURPOSE: To evaluate the resource implications of different delivery models for the provision of additional findings (AF) in genom..

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

Koen Degeling, Hui-Li Wong, Hendrik Koffijberg, Azim Jalali, Jeremy Shapiro, Suzanne Kosmider, Rachel Wong, Belinda Lee, Matthew Burge, Jeanne Tie, Desmond Yip, Louise Nott, Adnan Khattak, Stephanie Lim, Susan Caird, Peter Gibbs, Maarten IJzerman

Journal article  |  2020  |  PharmacoEconomics

BACKGROUND: Simulation models utilizing real-world data have potential to optimize treatment sequencing strategies for specific pa..

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Wanyuan Cui, Fanny Franchini, Marliese Alexander, Ann Officer, Hui-Li Wong, Maarten IJzerman, Jayesh Desai, Benjamin J Solomon

Journal article  |  2020  |  Lung Cancer

BACKGROUND: KRAS mutations are found in 20-30 % of non-small cell lung cancers (NSCLC) and were traditionally considered undruggab..

Evaluating theAge-BasedRecommendations forLong-Term Follow-Upin Breast Cancer

Annemieke Witteveen, Linda de Munck, Catharina GM Groothuis-Oudshoorn, Gabe S Sonke, Philip M Poortmans, Liesbeth J Boersma, Marjolein L Smidt, Ingrid MH Vliegen, Maarten J IJzerman, Sabine Siesling

Journal article  |  2020  |  The Oncologist

Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence?

Luiza Raquel Grazziotin, Gillian Currie, Michelle MA Kip, Maarten J IJzerman, Marinka Twilt, Raymond Lee, Deborah A Marshall

Journal article  |  2020  |  PharmacoEconomics

CANCER RISK AND RESOURCE UTILIZATION FOR 5 COMMON CANCERS IN A MATCHED CHINESE DIABETES POPULATION OF 331,000 PATIENTS

N Wu, PM Clarke, A Palmer, B Cui, L Wang, M IJzerman

Conference Proceedings  |  2020  |  VALUE IN HEALTH

IMPROVING ACCURACY OF RECORD LINKAGE USING GRAPH STRUCTURES: RELEVANCE FOR HEALTH OUTCOMES RESEARCH?

N IJzerman, P Lin, M IJzerman, U Aickelin

Conference Proceedings  |  2020  |  Value in Health

Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group

Eric Faulkner, Anke-Peggy Holtorf, Surrey Walton, Christine Y Liu, Hwee Lin, Eman Biltaj, Diana Brixner, Charles Barr, Jennifer Oberg, Gurmit Shandhu, Uwe Siebert, Susan R Snyder, Simran Tiwana, John Watkins, Maarten J Ijzerman, Katherine Payne

Journal article  |  2020  |  Value in Health

Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling

Deborah A Marshall, Luiza R Grazziotin, Dean A Regier, Sarah Wordsworth, James Buchanan, Kathryn Phillips, Maarten Ijzerman

Journal article  |  2020  |  Value in Health

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review

Frederik van Delft, Hendrik Koffijberg, Valesca Retel, Michel van den Heuvel, Maarten IJzerman

Journal article  |  2020  |  Cancers

With the introduction of targeted therapies and immunotherapy, molecular diagnostics gained a more profound role in the management..